Clinical Aspects of Inhibition of Ornithine Decarboxylase with Emphasis on Therapeutic Trials of Eflornithine (DFMO) in Cancer and Protozoan Diseases

This publication has 49 references indexed in Scilit:

• Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro
  Antimicrobial Agents and Chemotherapy, 1985
• Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effects on murine trypanosomiasis
  Biochemical Pharmacology, 1985
• Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic Considerations
  Annals of Internal Medicine, 1984
• Present status of chemotherapy and chemoprohylaxis of human trypanosomiasis in the Eastern Hemisphere
  Pharmacology & Therapeutics, 1980
• Intracellular putrescine and spermidine deprivation induces increased uptake of the natural polyamines and methylglyoxal bis(guanylhydrazone)
  Biochemical Journal, 1980
• Polyamine Metabolism: A Potential Therapeutic Target in Trypanosomes
  Science, 1980
• Inhibition of murine embryonic development by α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase
  European Journal of Pharmacology, 1980
• L-Ornithine Decarboxylase: an Essential Role in Early Mammalian Embryogenesis
  Science, 1980
• Synthesis and Content of Polyamines in Bloodstream Trypanosoma brucei*
  The Journal of Protozoology, 1979
• Skin polyamine levels in psoriasis: the effect of dithranol therapy*
  European Journal of Clinical Investigation, 1978